News
Bristol Myers Squibb plans to inject $40 billion into U.S. operations over the next five years, mixing business ambition with ...
US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback